Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment

The development of immunotherapy, in particular immune checkpoint inhibitors (ICI), has revolutionized cancer treatment in the past decades. However, its efficacy is still limited to subgroups of patients with cancer. Therefore, effective treatment combination strategies are needed. Here, radiothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Kleinendorst, Simone C., Oosterwijk, Egbert, Bussink, Johan, Westdorp, Harm, Konijnenberg, Mark W., Heskamp, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433955/
https://www.ncbi.nlm.nih.gov/pubmed/35471557
http://dx.doi.org/10.1158/1078-0432.CCR-21-4332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433955/
https://www.ncbi.nlm.nih.gov/pubmed/35471557
http://dx.doi.org/10.1158/1078-0432.CCR-21-4332

Ejemplares similares